• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4602291)   Today's Articles (42)   Subscriber (49368)
For: Cytarska J, Anisiewicz A, Baranowska-Łączkowska A, Sikora A, Wietrzyk J, Misiura K, Łączkowski KZ. Triazene salts: Design, synthesis, ctDNA interaction, lipophilicity determination, DFT calculation, and antiproliferative activity against human cancer cell lines. Saudi Pharm J 2019;27:303-311. [PMID: 30976172 PMCID: PMC6438848 DOI: 10.1016/j.jsps.2018.11.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2018] [Accepted: 11/22/2018] [Indexed: 11/26/2022]  Open
Number Cited by Other Article(s)
1
Figueirêdo PDMS, Sampaio Filho JC, Sodré ADJS, de Castro Júnior JR, Gonçalves IS, Blasques RV, S Correa R, Lima BAV, Dos Anjos Marques L, Coutinho DF, de Azevedo Dos Santos APS, Luz TRSA, de Miranda RDCM, Dos Santos JRA, Doriguetto AC, Pividori MI, Hörner M, Villis PCM. Assessment of the biological potential of diaryltriazene-derived triazene compounds. Sci Rep 2021;11:2541. [PMID: 33510223 PMCID: PMC7844262 DOI: 10.1038/s41598-021-81823-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Accepted: 01/11/2021] [Indexed: 01/21/2023]  Open
2
Francisco AP, Mendes E, Santos AR, Perry MJ. Anticancer Triazenes: from Bioprecursors to Hybrid Molecules. Curr Pharm Des 2020;25:1623-1642. [PMID: 31244412 DOI: 10.2174/1381612825666190617155749] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2019] [Accepted: 05/20/2019] [Indexed: 11/22/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA